Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KLK10 |
| Upstream (Parents) |
|---|
| (<<) S100A11 → KLK10 |
| (<<) KLK6 → KLK10 |
| (<<) S100A11P1///S100A11 → KLK10 |
| (<<) PLAUR → KLK10 |
| (<<) KLK11 → KLK10 |
| Downstream (Children) |
|---|
| KLK10 → DMRT1 (>>) |
| KLK10 → ZNF717 (>>) |
| KLK10 → IGHA1 (>>) |
| KLK10 → AHNAK2 (>>) |
| KLK10 → MME (>>) |
| KLK10 → ULBP2 (>>) |
| KLK10 → CHRNA1 (>>) |
| KLK10 → MARCH3 (>>) |
| KLK10 → SCEL (>>) |
| KLK10 → CXCL1 (>>) |
| KLK10 → KRT6B (>>) |
| KLK10 → EPHA2 (>>) |
| KLK10 → KLK6 (>>) |
| KLK10 → KLK7 (>>) |
| KLK10 → LCN2 (>>) |
| KLK10 → MINK1 (>>) |
| KLK10 → KCNK1 (>>) |
| KLK10 → NINL (>>) |
| KLK10 → KLK11 (>>) |
| KLK10 → IFI27 (>>) |
